YahooSeptember 11, 2026 at 9:38 AM NYLast Month
Up 36% in the Last 12 Months, Does Elevance Health Stock Have More Room to Run Through 2028?
Key Takeaways:Guidance Raised: Elevance Health lifted 2026 adjusted EPS guidance to at least $27, up from prior levels, after a strong Q2. Price Projection: Based on current execution, ELV stock could reach $494 by December 2028.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
